Steven Finkbeiner, MD, PhD, has conducted neuroscience research for over 25 years and led many projects funded by the NIH (National Institutes of Health). He invented robotic microscopy, a powerful cellular imaging technology that he uses to study the basic mechanisms of neurodegeneration. He has also led two critical collaborations with Google to develop deep learning computational approaches to better extract information from microscopic images. He is a founding member of the NIH Induced Pluripotent Stem Cell Consortium for Huntington Disease and has developed induced pluripotent stem cells for frontotemporal dementia, amyotrophic lateral sclerosis, Parkinson's disease (PD) and Alzheimer's disease. He also initiated family-based whole-genome analysis for PD and Huntington's disease and functional genomics in human induced pluripotent stem cells donated by people with these diseases. His service on National Institute of Neurological Disorders and Stroke (NINDS) Council, as a consultant to biotechnology and pharmaceutical companies, and as a member of Science Advisory Boards of multiple private foundations continues to broaden his understanding of leading-edge multidisciplinary research in neurodegenerative diseases.